Using a well-recognized mouse model, human primary samples and a xenograft model, we discovered that a new plasma membrane binding agent belonging to the Pyrido [4,3-b]quinoxaline (PyQ) family blocks the GM-CSF-dependent proliferation of AML leukemic cells. This evidence concerns the gene CSF2 and acute myeloid leukemia.